Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Wuhan Kindstar Diagnostics Raises $20 Million for Testing Services

publication date: Mar 5, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Wuhan Kindstar Diagnostics has raised $20 million in a C round from western investors. Kindstar will use the money to expand the esoteric testing services the company offers to China hospitals. It currently services over 2,000 hospitals in 320 cities located in every one of China’s provinces. The China arm of Kleiner Perkins Caufield & Byers contributed $16 million of the total. The remaining $4 million was raised from existing investors WI Harper Group and Baird Capital Partners Asia. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
ChinaBio Leadership Retreat 2014
Suzhou, China
October 23-24, 2014
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors